tiprankstipranks

Christopher Gibson Insider Profile

4 Followers
Christopher Gibson, Director at Recursion Pharmaceuticals, holds 906.56K shares in Recursion Pharmaceuticals (Ticker: RXRX), holds 53.91K shares in Pacific Biosciences (Ticker: PACB).
tipranks
Christopher Gibson

Christopher Gibson
Recursion Pharmaceuticals (RXRX)
Director

Ranked #76,604 out of 106,487 Corporate Insiders

Profitable Transactions

29%
8 out of 28 Profitable Transactions

Average Return

-5.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
97.49%
2.51%
A breakdown of Christopher Gibson's holdings

Insider Roles

Recursion Pharmaceuticals
(RXRX)
Director
Pacific Biosciences
(PACB)
Director
Roles that Christopher Gibson holds in companies

Most Profitable Insider Trade

Stock:
Recursion Pharmaceuticals
(RXRX)
Rating:Informative Buy
Date:May 05, 2023 - May 05, 2024
Return:+71.30%
The most profitable trade made by Christopher Gibson

Christopher Gibson's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Recursion Pharmaceuticals
Apr 08, 2026
Director
Uninformative Sell
124.00K
$3.07M
Pacific Biosciences
Mar 05, 2026
Director
Uninformative Buy
$79.25K
List of latest transactions for each holding click on a transaction to see Christopher Gibson's performance on stock

Christopher Gibson insider profile FAQ

What is the percentage of profitable transactions made by Christopher Gibson?
The percentage of profitable transactions made by Christopher Gibson is 29%.
    What is the average return per transaction made by Christopher Gibson?
    The average return per transaction made by Christopher Gibson is -5.10%.
      What stocks does Christopher Gibson hold?
      Christopher Gibson holds: RXRX, PACB stocks.
        What was Christopher Gibson’s latest transaction?
        Christopher Gibson latest transaction was an Uninformative Sell of $124.00K.
          What was Christopher Gibson's most profitable transaction?
          Christopher Gibson’s most profitable transaction was an Informative Buy of RXRX stock on May 5, 2023. The return on the trade was 71.30%.
            What is Christopher Gibson's role in Recursion Pharmaceuticals?
            Christopher Gibson's role in Recursion Pharmaceuticals is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.